Literature DB >> 15902905

First-pass metabolism of ethanol in human beings: effect of intravenous infusion of fructose.

Alexandr Parlesak1, Michael Hans-Ulrich Billinger, Christian Schäfer, Heinz-Dieter Wehner, Christiane Bode, Johann Christian Bode.   

Abstract

Intravenous infusion of fructose has been shown to enhance reduced form of nicotinamide adenine dinucleotide reoxidation and, thereby, to enhance the metabolism of ethanol. In the current study, the effect of fructose infusion on first-pass metabolism of ethanol was studied in human volunteers. A significantly higher first-pass metabolism of ethanol was obtained after administration of fructose in comparison with findings for control experiments with an equimolar dose of glucose. Because fructose is metabolized predominantly in the liver and can be presumed to have virtually no effects in the stomach, results of the current study support the assumption that only a negligible part of first-pass metabolism of ethanol occurs in the stomach.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15902905     DOI: 10.1016/j.alcohol.2004.06.009

Source DB:  PubMed          Journal:  Alcohol        ISSN: 0741-8329            Impact factor:   2.405


  2 in total

1.  Combining Varenicline (Chantix) with Naltrexone Decreases Alcohol Drinking More Effectively Than Does Either Drug Alone in a Rodent Model of Alcoholism.

Authors:  Janice C Froehlich; Stephen M Fischer; Julian E Dilley; Emily R Nicholson; Teal N Smith; Nick J Filosa; Logan C Rademacher
Journal:  Alcohol Clin Exp Res       Date:  2016-07-29       Impact factor: 3.455

2.  Prazosin reduces alcohol drinking throughout prolonged treatment and blocks the initiation of drinking in rats selectively bred for high alcohol intake.

Authors:  Janice C Froehlich; Brett J Hausauer; David L Federoff; Stephen M Fischer; Dennis D Rasmussen
Journal:  Alcohol Clin Exp Res       Date:  2013-06-03       Impact factor: 3.455

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.